Biologics and recombinant biopharmaceuticals range in complexity from simple, insulin-like products to chimeric, monoclonal antibodies. Accurate characterization of these products involves capital intensive equipment, a wide variety of methods of analyses and global quality compliance in all aspects of infrastructure, quality systems and documentation. Please check out:
Click to know the tests carried out for each of the above types of these:
Choose from our wide range of services to fulfill your requirements.